Provision for Income Taxes (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Income Tax Disclosure [Abstract] | ||||
| Income tax (benefit) expense | $ (7,763) | $ 3,884 | $ (26,018) | $ 6,574 |
| Discrete tax benefit for completion of a research and development tax credit study | 20,100 | |||
| Income tax benefit related to acquisition | 11,100 | |||
| Ordinary tax expense | $ 5,000 | |||
| X | ||||||||||
- Definition Effective Income Tax Rate Reconciliation, Deduction, Business Combination, Amount No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|